Cargando…

CAR-T: a potential gene carrier targeting solid tumor immune microenvironment

Detalles Bibliográficos
Autores principales:	Wang, Minjie, Zhang, Chaocai, Jiang, Xiaobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585982/ https://www.ncbi.nlm.nih.gov/pubmed/34764238 http://dx.doi.org/10.1038/s41392-021-00812-z

Ejemplares similares

Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
por: Li, Feng, et al.
Publicado: (2019)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma
por: Wang, Minjie, et al.
Publicado: (2022)

The interferon-γ receptor pathway: a new way to regulate CAR T cell-solid tumor cell adhesion
por: Hong, Lingjuan, et al.
Publicado: (2022)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

Digitally deconvolving the tumor microenvironment
por: Aran, Dvir, et al.
Publicado: (2016)

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma
por: Wang, Minjie, et al.
Publicado: (2021)

Step further towards targeted senolytic therapy: therapeutic potential of uPAR-CAR T cells for senescence-related diseases
por: Huang, Yujia, et al.
Publicado: (2020)

Barring the gates to the battleground: DDR1 promotes immune exclusion in solid tumors
por: Wagner, Dimitrios L., et al.
Publicado: (2022)

Immune‐related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients
por: Yu, Hao, et al.
Publicado: (2022)

Current approaches to increase CAR T cell potency in solid tumors: targeting the tumor microenvironment
por: Scarfò, Irene, et al.
Publicado: (2017)

Competition for nutrients or cell intrinsic programming? – Metabolic mechanisms behind the tumor promoting immune microenvironment in cancer
por: Niu, Yuequn, et al.
Publicado: (2021)

Serial progression of cortical and medullary thymic epithelial microenvironments
por: Alves, Nuno L, et al.
Publicado: (2014)

Segregating memories: targeting microenvironment of neuronal ensembles
por: Liu, Ying, et al.
Publicado: (2022)

Tuning the rheostat of immune gene translation
por: Huang, Shuai
Publicado: (2023)

The thioredoxin system: Balancing redox responses in immune cells and tumors
por: Muri, Jonathan, et al.
Publicado: (2022)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
por: Wang, Yufeng, et al.
Publicado: (2023)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors
por: Wang, Yufeng, et al.
Publicado: (2023)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors
por: Johnson, Abigail, et al.
Publicado: (2022)

A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment
por: Ng, Susanna S., et al.
Publicado: (2021)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

Clonal replacement of novel T cells: a new phenomenon in the tumor microenvironment following PD-1 blockade
por: Li, Xue, et al.
Publicado: (2019)

Neutrophil-sourced TNF in cancer: deciphering an intricate orchestrator of immunosuppressive communication in the tumor microenvironment
por: Zhao, Xinyuan, et al.
Publicado: (2023)

Targeting α7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury
por: Shin, Samuel S., et al.
Publicado: (2015)

CAR T cells remain during long-term cancer remission
por: Barnes, Katharine
Publicado: (2022)

B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
por: Tian, Xinyu, et al.
Publicado: (2023)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
por: Martinez, Marina, et al.
Publicado: (2019)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

Molecular carriers of acquired inheritance: absence of evidence is not evidence of absence
por: Shi, Junchao, et al.
Publicado: (2016)

Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells
por: Charo, Jehad, et al.
Publicado: (2021)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Switchable targeting of solid tumors by BsCAR T cells
por: Stepanov, Alexey V., et al.
Publicado: (2022)

Insights into coronavirus immunity taught by the murine coronavirus
por: Grabherr, Sarah, et al.
Publicado: (2021)

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
por: Li, Weizhen, et al.
Publicado: (2021)

Mitochondrial pyruvate carrier: a metabolic-epigenetic checkpoint orchestrating T cell differentiation
por: Chen, Yu, et al.
Publicado: (2022)

WeiTsing: a new face of Ca(2+)-permeable channels in plant immunity
por: Wang, Feng-Zhu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fu040d2bhl2nf84lg9ple3ef76